硫酸镁联合山莨菪碱湿敷预防长春瑞滨致静脉炎及疼痛的效果观察

目的：探讨硫酸镁联合山莨菪碱湿敷预防长春瑞滨致静脉炎及疼痛的效果。方法：将应用长春瑞滨联合顺铂化疗的84例患者随机分为观察组和对照组各42例,对照组采用输注长春瑞滨前5 min沿患者血管走向穿刺点上方3～5 cm局部常规应用冰块冷敷,观察组采用输注长春瑞滨前5 min应用0℃、33%硫酸镁加2%山莨菪碱混合液纱布湿敷。结果：2个疗程化疗结束后,观察组静脉炎发生率及局部疼痛程度明显低于对照组（P〈0.01）。结论：硫酸镁联合山莨菪碱湿敷能有效降低长春瑞滨所致静脉炎的发生,镇痛效果明显。     

酒精湿敷加喜辽妥联合地塞米松对防治长春瑞滨致化疗性静脉炎的临床观察

目的:比较酒精湿敷加喜辽妥联合地塞米松对长春瑞滨致化疗性静脉炎的防治作用。方法:将64例非小细胞肺癌患者随机分为两组,化疗方案选择长春瑞滨加顺铂,在静脉滴注长春瑞滨前后用生理盐水100ml加地塞米松5mg静脉滴注,A组患者选择用酒精湿敷局部加喜辽妥外用,而B组应用50%硫酸镁冷湿敷,比较两组患者静脉炎发生及局部疼痛情况。结果:A组静脉炎发生率明显低于B组,并且疼痛反应的发生较B组少,两组差别具有统计学意义。结论:应用酒精湿敷加喜辽妥对防治静脉输注长春瑞滨致化疗性静脉炎疗效优于50%硫酸镁冷湿敷,其疗效确切,方法简单,值得临床推广。     

美皮康预防长春瑞滨所致静脉炎的效果

目的探讨美皮康外贴预防长春瑞滨所致静脉炎的疗效。方法对126例使用长春瑞滨的患者随机分为对照组62例和观察组64例,两组在静脉输注长春瑞滨前、后给予地塞米松盐水,对照组用硫酸镁湿纱布冷湿敷穿刺部位及上方沿静脉走行8～15cm;观察组用美皮康代替硫酸镁湿纱布外贴,观察两组患者局部组织反应及静脉炎的发生率。结果两组静脉炎发生情况差异有统计学意义（P〈0．01）,观察组静脉炎的发生率及严重程度均明显低于对照组。结论美皮康外贴穿刺部位可降低长春瑞滨所致静脉炎的发生率,且使用方便、舒适,患者乐意接受,值得临床推广。     

地塞米松静脉注射联合芦荟外涂防治长春瑞滨致局部反应的效果观察

[目的]观察地塞米松芦荟联合应用对长春瑞滨所致局部反应的防治作用。[方法]将静脉输注长春瑞滨化疗的48例肿瘤病人分成两组,对照组输注长春瑞滨前后各静脉输注地塞米松5mg,再用生理盐水500mL快速输注,后用冰块冷敷局部12h。实验组在对照组基础上采用新鲜芦荟汁外涂。[结果]实验组手臂红肿、胀痛、静脉炎发生率明显低于对照组(P<0.01);疼痛程度轻,疼痛持续时间缩短。[结论]地塞米松芦荟联合应用能有效防治长春瑞滨对局部组织的损伤。     

地塞米松静脉注射联合芦荟外涂防治长春瑞滨致局部反应的效果观察

[目的]观察地塞米松芦荟联合应用对长春瑞滨所致局部反应的防治作用。[方法]将静脉输注长春瑞滨化疗的48例肿瘤病人分成两组，对照组输注长春瑞滨前后各静脉输注地塞米松5mg，再用生理盐水500mL快速输注，后用冰块冷敷局部12h。实验组在对照组基础上采用新鲜芦荟汁外涂。[结果]实验组手臂红肿、胀痛、静脉炎发生率明显低于对照组（P〈0.01）；疼痛程度轻，疼痛持续时间缩短。[结论]地塞米松芦荟联合应用能有效防治长春瑞滨对局部组织的损伤。     

冰敷加喜辽妥联合地塞米松预防诺维本致局部静脉炎的疗效观察

[目的]比较冰敷加喜辽妥与硫酸镁冷湿敷两组联合地塞米松对诺维本致静脉炎的疗效观察。[方法]将64例静脉输注诺维本的病人随机分为两组,在治疗前10min～15min均用地塞米松静脉推注,观察组用冰敷加喜辽妥外用,对照组用50%硫酸镁冷湿敷,观察两组局部反应情况。[结果]两组病人局部镇痛效果及发生静脉炎的疗效比较具有统计学意义(P<0.05)。[结论]应用冰敷加喜辽妥对静脉输注诺维本所致的静脉炎疗效优于50%硫酸镁冷湿敷,值得临床推广。     

不同时间使用硫酸镁湿敷预防刺激性静脉炎的疗效比较

68例癌症患者应用长春新碱类化疗药物,实验组在应用化疗药的同时即给患者沿静脉走向行33%硫酸镁湿敷,对照组待患者出现静脉红肿、疼痛时再给予33%硫酸镁湿敷加其他疗法.两组进行对照,结果实验组的静脉炎发生率明显低于对照组.     

山莨菪碱联合硫酸镁湿敷治疗下肢深静脉血栓43例临床护理

目的:探讨山莨菪碱联合硫酸镁湿敷治疗下肢深静脉血栓(DVT)的临床护理方法。方法:将83例DVT患者随机分为观察组43例和对照组40例,对照组患者给予抗凝溶栓治疗及50%硫酸镁局部湿敷,观察组给予抗凝溶栓治疗及山莨菪碱联合50%硫酸镁局部交替湿敷,治疗5 d后分析比较两组疗效。结果:观察组治愈22例,显效17例,有效3例,无效1例;对照组治愈13例,显效7例,有效11例,无效9例。两组治疗有效率比较差异有统计学意义(P<0.01)。结论:山莨菪碱联合50%硫酸镁湿敷治疗DVT疗效明显优于单用50%硫酸镁,值得临床推广。     

25％硫酸镁联合2％利多卡因预防化疗性静脉炎的效果观察

目的探讨25％硫酸镁联合2％利多卡因局部湿敷预防化疗性静脉炎的效果。方法将108例消化系统恶性肿瘤化疗患者按治疗开始顺序分为两组，观察组54例静脉化疗用25％硫酸镁联合2％利多卡因局部湿敷，对照组54例用新鲜马铃薯片湿敷，观察两组静脉炎发生情况及程度。结果观察组静脉炎6例，对照组14例，χ^2=3．93，P〈0．01；观察组Ⅰ度、Ⅱ度静脉类分别为4例、2例，对照组Ⅰ度、Ⅱ度静脉炎分别为9例、5例，U=1．91，P〈0．05。结论25％硫酸镁联合2％利多卡因局部湿敷可明显降低化疗性低静脉炎的发生率和减轻静脉炎的程度。     

榄香烯乳注射液致静脉炎的预防及护理

将80例应用榄香烯乳注射液行外周静脉滴注化疗的癌症病人,随机分为观察组与对照组各40例,观察组采用生理盐水静脉穿刺成功后再接上榄香烯乳液静滴,输注完毕再输注生理盐水10ml及50%硫酸镁局部湿敷的方法,对照组采用榄香烯乳液0.4g加入5%葡萄糖或生理盐水300ml中静脉滴注方法,观察比较两组病人局部静脉红肿、疼痛情况.结果显示,观察组静脉炎的发生明显低于对照组(P<0.01).作者认为观察组操作方法可有效防治榄香烯乳静滴所致的静脉炎.     

超声评分对膝骨性关节炎患者病变特点的评估价值

目的 探讨超声评分对膝骨性关节炎患者病情严重度的诊断价值。方法 回顾性收集我院收治的膝骨性关节炎患者52例,同期收集50例健康成人,分析超声评分与膝骨性关节炎患者病情严重度的相关性。结果 膝骨性关节炎患者超声评分显著高于健康成人(6.93±1.76 vs. 1.73±0.56,P=0.000)。膝骨性关节炎患者超声评分与髌上囊液体深度、髌下囊液体深度、关节腔液体深度、滑膜厚度显著正相关(r=0.265、0.216、0.310和0.255,P=0.004、0.035、0.000和0.012),与Lyshsolm显著负相关(r=-0.381,P=0.000)。与增生滑膜内血管阴性的患者相比,增生滑膜内血管阳性的患者超声评分显著增加(7.43±1.61 vs. 5.58±1.42, P=0.000)。结论 超声评分与膝骨性关节炎患者病情严重度相关。     

Use of the Role Checklist with the patient with multiple personality disorder

A paucity of occupational therapy evaluation tools exists for use with patients with multiple personality disorder. The Model of Human Occupation (Kielhofner & Burke, 1980), particularly the volition and habituation subsystems within this model, proved useful for the identification of the many facets of patients with multiple personality disorder on a short-term treatment unit. The Role Checklist (Oakley, Kielhofner, Barris, & Richler, 1986), a tool derived from the Model of Human Occupation, was adapted for use with this population and was found to be beneficial in the identification of common goals held by most of the personalities of each patient with multiple personality disorder. The use of the Role Checklist is illustrated with a case example.     

Living with a woman with fibromyalgia from the perspective of the husband

BACKGROUND: Fibromyalgia (FM) is a chronic pain syndrome, which affects mostly middle-aged women. The syndrome is poorly understood and treatment is mainly palliative. The diagnosis is established from diagnostic criteria. Living with FM means living a life greatly influenced by the illness in various ways for people affected. Aim of the study. The aim of this study was to describe the experiences of living with a woman with FM from the husbands' perspective. METHODS: Five men married to women with FM were interviewed using a narrative approach. The interviews were analysed using qualitative thematic content analysis. FINDINGS: The analysis resulted in the following seven themes: increasing responsibility and work in the home; being an advocate for and supporting the wife; learning to see the woman's changing needs; changing relationship between spouses; changing relationship with friends and relatives; deepening relationship with the children and lacking information and knowledge about FM. The findings show that the women's illness had a great impact on husbands' lives, and that husbands lacked information about the woman's illness. CONCLUSION: This study shows that it is not only the women with FM who experience a changed life; the whole family life is influenced and limited by FM. The husband's role in the family changes, first and foremost concerning responsibility and workload within the family. This must be taken into consideration in care planning. This study also highlighted the need of information and knowledge about FM expressed by the participants, information that health care personnel have a great responsibility to give.     

Experience with the use of plasmapheresis in the combined treatment of children with the crush syndrome

Plasmapheresis (PP) was applied to the treatment of 5 children aged 6-14 years with the crush syndrome. The multimodality treatment using antibiotics, erythrocytic mass, rheologically active preparations, hemodialysis and blood rheologically active preparations, hemodialysis and hemoperfusion carried out for 6-7 days before PP did not bring about any appreciable improvement of the patients' status. The patients failed to get rid of anuria and manifested the signs of increasing intoxication. The treatment with PP consisted of 1 to 6 procedures, in the course of which 70 to 85 of the design volume of the circulating plasma was removed. The use of PP resulted in the disappearance of myoglobin from the patients' blood and urine, in the normalization of the coagulogram, a considerable decrease of the content of medium molecules, and in the appearance of the first urine towards the end of the procedure. Thus, the introduction of PP into multimodality treatment of the crush syndrome made it possible to eliminate anuria, disseminated intravascular coagulation, and to noticeably reduce intoxication and to clear the blood off myoglobin.